AI assistant
CONMED Corp — Director's Dealing 2015
Mar 3, 2015
31971_dirs_2015-03-03_9fff8e06-98a0-4a78-b418-4298a9075e7c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2015-02-27
Reporting Person: Beyer Pat (President-Conmed International)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-27 | Rsus (restricted Stock Units) | $0 | A | 2700 | Acquired | 2025-02-27 | Common Stock (2700) | Direct |
| 2015-02-27 | Sars (Stock Appreciation Rights) | $51.30 | A | 50700 | Acquired | 2025-02-27 | Common Stock (50700) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Plan and generally vest in equal amounts (20%) over a five year period.